Cell Signaling Technology (CST) published a blog post showing how CST antibodies and matched pairs support protein quantification, TPD degradation and ubiquitination assays, target engagement and ternary complex readouts, and competition formats for small-molecule binding.
Public source
Publisher name
Public post
A versatile, no-wash assay that’s amenable to high‑throughput, automated drug discovery workflows? That’s TR-FRET in action. In the latest #CSTblog, we show how CST anti…
Company
Cell Signaling Technology (CST)
CST is a private, family-owned company, founded by scientists and dedicated to providing high-quality research tools.
- Industry
- Biotechnology Research
- Location
- Danvers, US
- Company size
- 1,001–5,000 employees
About Cell Signaling Technology (CST)
As a company founded and led by research scientists, we’re working to help unlock the secrets of life. To empower the global scientific community, accelerate biological understanding, and enable personalized medicine. And we believe in the power and promise of science to solve the challenges we face as a global community. Because we’re scientists, we understand your needs as a researcher. We know what it takes to achieve meaningful results— the patience, rigor, sacrifice, and dedication. And we know you have to be able to rely on the tools you use in your investigations, whether in an academic setting or an industry one. That’s why we’re so fanatical about the quality of our antibodies and other products. And why we’re dedicated to providing our customers with the best possible service and support. Engaging in solutions-focused consultation and support is a foundational part of who we are and what we do. Every day, we work to develop innovative, proven solutions that can help you find the answers you’re looking for—answers that can lead to better understanding, diagnosis, and treatment of disease.
See moreLatest activity
Latest activity from Cell Signaling Technology (CST)
4 signals
Strategy & Corporate Development
Cell Signaling Technology (CST) is following a detailed, multifaceted, and phased plan to measure all scopes of greenhouse gas emissions and offset the remaining footprint through effective, closely vetted projects.
Research & Knowledge
Cell Signaling Technology (CST) provides antibody sampler kits to learn whether Bcl-2 family members are contributing to cell death resistance in cancer cells.
Presence & Recognition
Cell Signaling Technology (CST) announced the hiring of Mike Johnson to lead the company's global research and development team.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Celtarys Research
Celtarys Research developed VHL and CRBN binding assay kits to test engagement in PROTAC and molecular glue projects.
Research & Knowledge
Panome Bio
Panome Bio published a blog exploring how surface proteomics helps with target discovery, early safety assessment, biomarker discovery, and resistance research.
Research & Knowledge
Protein & Structure - Sygnature Discovery
Protein & Structure - Sygnature Discovery published a blog exploring why bringing functional and structural perspectives together can strengthen membrane protein drug discovery.
Research & Knowledge
BioLegend
BioLegend published a blog post explaining how FluoroSpot MAX™ Deluxe Sets enable simultaneous detection of multiple secreted proteins at the single-cell level for immune monitoring studies.
Research & Knowledge
Pelago Bioscience AB